Clinical landscape of oncolytic virus research in 2020 by Howard L Kaufman, Rizwan Haq, Nicholas Macedo, David M Miller

Get full text

Combination immunotherapy: a road map by F. Stephen Hodi, Jedd D. Wolchok, Howard L. Kaufman, Patrick A. Ott, Jon M. Wigginton

Get full text

Cytokine-armed oncolytic herpes simplex viruses: a game-changer in cancer immunotherapy? by Howard L Kaufman, Hongbin Wang, Dipongkor Saha, Samuel D Rabkin, Mia Borlongan, Uyen Le, Hans J Nauwynck

Get full text

Defining current gaps in quality measures for cancer immunotherapy: consensus report from the Society for Immunotherapy of Cancer (SITC) 2019 Quality Summit by Antonia R Sepulveda, Howard L Kaufman, Robert Carlson, Sara Pai, David Blaisdell, Rachel Brodie, Heidi Finnes, Michele Galioto, Roxanne E Jensen, Tom Valuck

Get full text

Defining best practices for tissue procurement in immuno-oncology clinical trials: consensus statement from the Society for Immunotherapy of Cancer Surgery Committee by Lisa H Butterfield, Howard L Kaufman, Steven A Rosenberg, Simon Turcotte, Robert L Ferris, Craig L Slingluff, David Byrd, Jyothi Sethuraman, Brian Gastman, Michael Lim, Michael T Lotze, Mokenge Malafa, Adekunle Odunsi, Fumito Ito, Genevieve Boland, Pranav Murthy, Adam Berger, Haider Mahdi, Piyush K Agarwal, Stephen Broderick, Peter E Fecci, Yuman Fong, Stephanie L Goff, Matthew M Grabowski, Carol D Morris, Rogerio I Neves, Sara I Pai, Sangeetha Prabhakaran, Ragheed Saoud, Joseph Skitzki, Vernon K Sondak, John B Sunwoo, Cecilia CS Yeung

Get full text